Items Tagged ‘abbvie’

March 28, 2018

AbbVie and the International Myeloma Foundation Partner to Study Role of a Genetic Mutation in Multiple Myeloma

By

AbbVie a research and development-based global biopharmaceutical company, and the International Myeloma Foundation (IMF) today announced they have entered into a collaboration to conduct a landmark retrospective chart review study to better understand and help manage multiple myeloma (MM), the second most common blood cancer.1 “There are significant knowledge gaps about multiple myeloma, and among […]

View full entry

Tags: abbvie, Multiple Myeloma, myeloma treatment, News, Precision Cancer Medicine